Market Fallers: Aviva plc, Anglo American plc, AstraZeneca plc, BAE Systems plc, Barclays PLC & BP plc

Aviva Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares in Aviva plc ticker lookup code: LON:AV has moved down -2.52% or -10.7 points throughout today’s trading session so far. Sellers were far from a positive bunch throughout the session. The high for the period has reached 426.4 and hitting a low of 413.4. Volume total for shares traded during this period was 3,728,620 with the daily average at 9,977,072. A 52 week share price high is 554.6 equating to 130.1 points difference from the previous close and the 52 week low at 361.8 making a difference of 62.7 points. Aviva plc now has a 20 moving average of 431.13 and now its 50 day moving average of 424.39. The current market cap is £16,151.99m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Aviva plc being recorded at Friday, March 22, 2019 at 12:02:18 PM GMT with the stock price trading at 413.8 GBX.

 

The trading price for Anglo American plc company symbol: LON:AAL has declined -2.07% or -41.7 points in today’s trading session so far. Traders have not remained optimistic throughout the trading session. The high for the period has reached 2024.5 dipping to 1976.6. The total volume of shares exchanged so far has reached 728,907 with the daily average traded share volume around 4,177,873. The 52 week high is 2078.5 amounting to 60 points different to the previous business close and a 52 week low sitting at 1433.64 which is a variance of 584.86 points. Anglo American plc now has a 20 moving average of 2025.75 and also a 50 day simple moving average now at 1957.12. This puts the market capitalisation now at £27,761.30m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for Anglo American plc being recorded at Friday, March 22, 2019 at 12:02:29 PM GMT with the stock price trading at 1976.8 GBX.

 

Stock in AstraZeneca plc company symbol: LON:AZN has dropped -2.25% or -150 points during today’s session so far. Market sellers were not positive during this period. The periods high has reached 6468 meanwhile the session low reached 6375. The total volume of shares exchanged through this period comes to 422,388 whilst the daily average number of shares exchanged is just 2,507,011. The stock 52 week high is 6540 which comes in at 15 points in difference on the previous days close and a 52 week low being 4746 is a variance of 1779 points. AstraZeneca plc now has a 20 SMA at 6322.55 and now the 50 day SMA of 5975.12. The current market capitalisation is £80,789.59m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Friday, March 22, 2019 at 12:02:23 PM GMT with the stock price trading at 6375 GBX.

 

Shares in BAE Systems plc with ticker code: LON:BA has stepped down -1.97% or -9.6 points during today’s session so far. Sellers have so far given a mostly negative outlook throughout the trading session. The high for the period has peaked at 489.9 meanwhile the session low reached 476. The total volume of shares exchanged so far has reached 2,143,758 while the average shares exchanged is 8,344,179. A 52 week high for the stock is 680.6 amounting to 194 points in difference to the previous days close of business and a 52 week low sitting at 441.5 is a variance of 45.1 points. BAE Systems plc now has a 20 moving average of 476.52 with a 50 day moving average now of 500.59. The current market cap is £15,247.76m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for BAE Systems plc being recorded at Friday, March 22, 2019 at 12:02:26 PM GMT with the stock price trading at 477 GBX.

 

Shares of Barclays PLC found using EPIC: LON:BARC has slid -1.94% or -3.12 points in today’s trading session so far. Market sellers did not seem confident during this period. The high for the period has reached 162 dipping to 157.32. The volume total for shares traded up to this point was 13,873,345 whilst the average number of shares exchanged is 52,413,901. A 52 week share price high is 219.1 which comes in at 58.52 points different to the previous business close and a 52 week low sitting at 144.99 a difference of some 15.59 points. Barclays PLC now has a 20 SMA of 165.08 and the 50 day SMA of 162.98. The current market cap is £26,979.00m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Barclays PLC being recorded at Friday, March 22, 2019 at 12:02:28 PM GMT with the stock price trading at 157.46 GBX.

 

The trading price for BP plc ticker code: LON:BP has slid -1.37% or -7.7 points during today’s session so far. Market sellers did not seem confident during the session. The periods high figure was 563.5 and a low of 555.9. The total volume of shares exchanged through this period comes to 5,448,643 whilst the average number of shares exchanged is 36,147,286. The 52 week high price for the shares is 603.6 amounting to 39.8 points difference from the previous days close and the 52 week low at 457.35 a difference of some 106.45 points. BP plc has a 20 day moving average of 544.88 with a 50 day moving average now at 537.24. The current market capitalisation is £112,654.94m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for BP plc being recorded at Friday, March 22, 2019 at 12:02:19 PM GMT with the stock price trading at 556.1 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Aviva plc announces a strategic acquisition of Direct Line, enhancing its growth and performance. The deal offers benefits for both customers and shareholders.
    AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials.
    AstraZeneca's Imfinzi receives FDA approval for limited-stage small cell lung cancer, marking a significant breakthrough in extending patient survival.

      Search

      Search